If you require further searching capabilities for announcements please email: data@nzx.com

Fisher & Paykel Healthcare announces 2021 investor series

04/05/2021, 11:07 NZST, GENERAL

Stock Exchange Announcement STOCK EXCHANGE LISTINGS: NEW ZEALAND (FPH), AUSTRALIA (FPH) Fisher & Paykel Healthcare announces 2021 Investor Series Auckland, New Zealand, 4 May 2021 - Fisher & Paykel Healthcare Corporation Limited today announced it will hold a virtual Investor Series over three days between 1 June and 3 June 2021 (NZST). The Investor Series will provide participants with the opportunity to hear from management based in New Zealand and the United States on our technology and therapies and gain further insights into our strategy for long-term sustainable profitable growth. The series will be presented via webcast through three one-hour presentations over three days including Q&A sessions with management. Event: Fisher & Paykel Healthcare 2021 Investor Series Programme: Day 1 Introduction to sustainable profitable growth/Hospital Respiratory Support 1 June 2021, 1:00pm - 2:00pm NZST 1 June 2021, 11:00am - 12:00pm AEST 31 May 2021, 9:00pm - 10:00pm USEDT Day 2 Home Respiratory Support/Surgical Humidification 2 June 2021, 1:00pm - 2:00pm NZST 2 June 2021, 11:00am - 12:00pm AEST 1 June 2021, 9:00pm - 10:00pm USEDT Day 3 Expanding global reach/Concluding comments 3 June 2021, 1:00pm - 2:00pm NZST 3 June 2021, 11:00am - 12:00pm AEST 2 June 2021, 9:00pm - 10:00pm USEDT Please register at the following site and details on how to access the webcast will be provided to you prior to the event: https://www.fphcare.com/investor-series Investors and analysts will be able to ask questions via the webcast. While every endeavour will be made to answer all questions that are submitted, this may not be possible due to time constraints. Registrations close 30 May 2021. About Fisher & Paykel Healthcare Fisher & Paykel Healthcare is a leading designer, manufacturer and marketer of products and systems for use in acute and chronic respiratory care, surgery and the treatment of obstructive sleep apnea. The company's products are sold in over 120 countries worldwide. For more information about the company visit www.fphcare.com Ends Contacts: Media: Karen Knott Senior Communications Manager karen.knott@fphcare.co.nz +64 (0) 21 713 911 Investors: Hayden Brown Investor Relations Manager hayden.brown@fphcare.co.nz +64 (0) 27 807 8073 Authorised by: Marcus Driller VP Corporate and Company Secretary. End CA:00371621 For:FPH Type:GENERAL Time:2021-05-04 11:07:17